Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Anseculin HCl enters phase II clinical trials

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Dolasetron equiefficent to granisetron in chemotherapy-induced emesis

July 5, 1996

Regeneron, Medtronic to collaborate on Axokine delivery system

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

CRF earns positive results in phase I/II

June 28, 1996

Cypros is granted U.S. patent for CPC-211 dosing regimen

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...